Mikhail Batin

The evidence shows Batin publicly identifies with life extension and points to a book on transhumanism as addressing an underestimated task in the field, but it does not provide a concrete destination, roadmap, timeline, theory of change, or consistent public vision for ending aging or materially extending healthy lifespan. His aging-related databases and publications support field engagement, but they are not vision statements under this dimension.

Scientific impact applies, but the primary citation signal is weak: OpenAlex reports h-index 3, i10-index 2, 43 total citations, and only 6 works. The publications show some direct participation in aging/longevity research and databases, but citation weight is far below field-defining impact and there is no evidence of clinical translation or highly cited foundational papers.

The dimension applies because Batin appears associated with institution-building through Open Longevity and public longevity databases, but the provided evidence contains no disclosed personal investments, donations, grantmaking, fund allocation, or quantified resources deployed. Primary/independent academic sources corroborate Open Longevity affiliations and outputs, but not capital deployment by Batin personally.

Strategic taste applies because Batin has public longevity advocacy and some evidence of choosing field-relevant knowledge infrastructure themes, especially Open Genes. However, the provided evidence is thin on thesis formation, timing, contrarianism, counterfactual importance, capital deployment, or institution-building decisions. His transhumanist framing and focus on underestimated life-extension tasks suggest some coherent agenda-setting, but not enough to support a high score.

Field creation applies, but the evidence shows mainly coauthorship on public longevity data resources rather than clear founding of organizations, programs, communities, protocols, or funding paths. Open Genes and AgeMeta are useful field infrastructure that can make aging targets and transcriptomic aging data more legible, but the evidence does not establish Batin as founder, lead creator, or organizer.

The bravery_conviction dimension applies, but the provided evidence contains only weak signs of public pro-longevity advocacy and no documented professional downside, criticism, major personal risk, or self-experimentation. Batin publicly identifies with life extension/transhumanism and has worked on longevity databases and publications, but the evidence does not establish that these involved contrarian public risk-taking or sustained conviction under pressure.

Multiplier effect applies, but the provided evidence shows only limited second-order leverage. Primary bibliometric evidence indicates participation in a small set of aging-related publications/databases with modest citation uptake, including collaborative work, which suggests some field contribution beyond direct advocacy. However, there is no documented evidence of founded organizations, investments, donations, policy influence, talent attraction, capital mobilization, public legitimacy gains, or major follow-on projects attributable to Batin. The self-published X profile supports an advocacy/framing role but cannot justify a higher result score by itself.